"Dihydroergotamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS.
| Descriptor ID |
D004087
|
| MeSH Number(s) |
D03.132.327.412.225 D03.633.400.562.300
|
| Concept/Terms |
DHE-45- DHE-45
- DHE 45
- DHE45
- D.H.E. 45
Dihydroergotamine Mesylate- Dihydroergotamine Mesylate
- Mesylate, Dihydroergotamine
- Dihydroergotamine Methanesulfonate
- Methanesulfonate, Dihydroergotamine
Migranal- Migranal
- Dihydergot
- Dihydroergotamine-Sandoz
- Dihydroergotamine Sandoz
|
Below are MeSH descriptors whose meaning is more general than "Dihydroergotamine".
Below are MeSH descriptors whose meaning is more specific than "Dihydroergotamine".
This graph shows the total number of publications written about "Dihydroergotamine" by people in this website by year, and whether "Dihydroergotamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dihydroergotamine" by people in Profiles.
-
Friedman BW, Kapoor A, Friedman MS, Hochberg ML, Rowe BH. The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials. Ann Emerg Med. 2008 Dec; 52(6):705-13.
-
Beisaw NE, Comerota AJ, Groth HE, Merli GJ, Weitz HH, Zimmerman RC, Diserio FJ, Sasahara AA. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial. J Bone Joint Surg Am. 1988 Jan; 70(1):2-10.